Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...
Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...
The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...